Tenon Medical, Inc. (TNON) has disclosed a new risk, in the Corporate Activity and Growth category.
Tenon Medical, Inc. faces significant business risk as it considers partnerships and collaborations that may not yield commercially successful products or substantial revenue. With no prior collaborations, the company’s inexperience could hinder successful negotiations or realization of expected benefits. Potential conflicts with partners over decision-making, performance milestones, or intellectual property rights could arise, adversely affecting Tenon’s interests. Additionally, disputes or termination of agreements may lead to increased expenses, management distraction, and loss of product rights, which could impede Tenon’s market position and business prospects.
The average TNON stock price target is $5.50, implying 478.95% upside potential.
To learn more about Tenon Medical, Inc.’s risk factors, click here.
